Put Options Event and Cash Market Context
On 2 April 2026, Sun Pharmaceutical Industries Ltd saw notable put option activity concentrated around three strikes expiring on 28 April 2026. The Rs 1,500 strike recorded 1,302 contracts traded with a turnover of ₹78.02 lakhs and an open interest of 489 contracts. Meanwhile, the Rs 1,600 and Rs 1,660 strikes saw even higher volumes, with 2,157 and 1,388 contracts traded respectively, and open interest of 984 and 446 contracts. The underlying stock price stood at Rs 1,661.40, down 4.35% on the day and having declined 8.35% over the past four sessions.
This combination of heavy put activity and a falling stock price sets the stage for a nuanced interpretation of the options data — is this a bearish bet, hedging, or put writing?
Strike Price Analysis: Moneyness and Distance from Underlying
The Rs 1,500 put strike lies approximately 9.7% below the current stock price of Rs 1,661.40, making it a significantly out-of-the-money (OTM) put. The Rs 1,600 strike is about 3.7% below the underlying, while the Rs 1,660 strike is almost at-the-money (ATM), just 0.07% below the current price. The concentration of contracts at these strikes, especially the Rs 1,600 and Rs 1,660 levels, indicates that traders are positioning around key support zones.
OTM puts like the Rs 1,500 strike typically serve as protection against a sharp downside move or as speculative bearish bets expecting a substantial decline. ATM and slightly OTM puts, such as Rs 1,660 and Rs 1,600, often reflect more immediate downside concerns or hedging against moderate pullbacks. The proximity of these strikes to the current price suggests a blend of hedging and directional bearish positioning.
Interpreting the Put Activity: Bearish, Hedging, or Put Writing?
Put option activity can signal different strategies depending on the context. In this case, the stock's recent downtrend and the put strikes' proximity to the current price point towards a directional bearish stance. The Rs 1,660 and Rs 1,600 strikes, with high volumes and open interest, suggest traders are either buying puts to profit from further declines or hedging existing long positions against near-term weakness.
Put writing, where traders sell puts to collect premium betting the stock will not fall below the strike, is less likely here given the stock's sustained weakness and the relatively low open interest compared to contracts traded. The Rs 1,500 strike, being deeply OTM, could be part of a spread strategy or a speculative bearish bet anticipating a sharp drop, but the overall data leans towards protective or bearish positioning rather than bullish put selling.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Open Interest and Contracts Analysis
The ratio of contracts traded to open interest provides insight into whether the activity represents fresh positioning or adjustments to existing positions. For the Rs 1,600 strike, 2,157 contracts traded against an open interest of 984, a ratio of approximately 2.2:1, indicating a significant but not overwhelming amount of fresh activity. The Rs 1,660 strike shows a similar pattern with 1,388 contracts traded versus 446 open interest, a ratio of about 3.1:1. The Rs 1,500 strike's ratio is higher at roughly 2.7:1.
These figures suggest a mix of new put buying and some position rollovers or adjustments. The relatively moderate open interest compared to traded contracts implies that traders are actively establishing or increasing bearish or protective positions rather than merely unwinding them.
Cash Market Context: Momentum and Moving Averages
Sun Pharmaceutical Industries Ltd has been under pressure recently, trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This broad weakness aligns with the put activity focused on strikes near and below the current price, reinforcing the interpretation of bearish positioning or hedging against further declines.
The stock's intraday low of Rs 1,620 on 2 April 2026, a 6.28% drop, further confirms the downward momentum. Delivery volumes have risen by 33.93% against the 5-day average, signalling increased investor participation amid the decline. This heightened activity may be driving the demand for puts as investors seek downside protection or to capitalise on the bearish trend — should traders consider this a sign of sustained weakness or a temporary correction?
Delivery Volume and Quality of Participation
The delivery volume of 24.1 lakh shares on 1 April 2026, up 33.93% from the recent average, indicates strong participation in the cash market. This suggests that the price decline is supported by genuine selling interest rather than low-liquidity fluctuations. The combination of rising delivery volumes and heavy put activity points to a cautious or bearish stance among market participants, who may be seeking to protect gains or limit losses amid the downtrend.
Get the full story on Sun Pharmaceutical Industries Ltd! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this Pharmaceuticals & Biotechnology large-cap. Make informed decisions!
- - Full research story
- - Sector comparison done
- - Informed decision support
Conclusion: Most Likely Interpretation of Put Activity
The heavy put option activity on Sun Pharmaceutical Industries Ltd at strikes close to and below the current price, combined with the stock’s sustained decline and trading below all major moving averages, points to a predominantly bearish positioning or protective hedging by investors. The Rs 1,660 and Rs 1,600 strikes, with their high volumes and open interest, suggest traders are bracing for further downside or seeking to limit losses on existing long positions.
Put writing as a bullish bet appears less likely given the market context and the stock’s recent underperformance. The Rs 1,500 strike activity may reflect speculative bearish bets or part of spread strategies, but the overall data favours a cautious or bearish outlook.
With the expiry on 28 April 2026 approaching, the options market is signalling a focus on downside risk management rather than outright bullish conviction — should investors interpret this as a warning or an opportunity to reassess their positions?
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
